shouldiuse.io

Categories

VERDICT

Should I use PharmaFootpath?

Pharmaceutical market intelligence: global drug pricing, suppliers, registrations, shortages, and trials in one searchable platform - pharmafootpath.com

Depends. A fit for small-to-mid pharma trade and sourcing teams wanting cross-market price, supplier, and shortage data without IQVIA's cost. Skip if you need published pricing, a self-serve trial, or enterprise analytics depth.

Confidence

Medium. Based on 11 public sources; independent user reviews limited to one Reddit thread.

Ratings

  • Value for moneyNo pricing evidence published
  • Ease of useNo usability evidence in sources
  • Feature depth
  • Support qualityNo support evidence in sources
  • Security posture

Pricing

Not disclosed

ModelNot disclosed
Monthly feesNot disclosed
HardwareNot disclosed

Best for

  • WDA licence holders sourcing internationally
  • Small-to-mid pharma import/export teams
  • Cross-market price and registration comparison
  • Shortage monitoring for sourcing decisions

Not for

  • Big pharma needing IQVIA-scale analytics and forecasting
  • Anyone outside pharma trade, wholesale, or sourcing
  • Buyers wanting published pricing or a free self-serve trial
  • Clinics or pharmacies seeking clinical reference data

Gotchas - check before you buy

medium

Pricing is unpublished; expect a demo-gated sales process before seeing any costs.

medium

Launched January 2024; data coverage in newer markets may still be maturing.

medium

Vendor incorporated November 2022 in Cardiff; small-company continuity risk for API-dependent workflows.

low

Security claims are self-attested policy statements; no independent audit evidence found.

Pros and cons

Pros

  • Unifies drug pricing, suppliers, registrations, shortages, and trials in one searchable platform
  • Clients in over 20 countries since first version launched
  • Trade-focused IQVIA alternative for WDA licence holders and sourcing teams
  • Developer API enables custom data integrations
  • Privacy policy documents MFA, role-based permissions, and incident response

Cons

  • No public pricing; sales starts with a 30-minute demo
  • First version only launched January 2024; young platform
  • Sparse independent reviews; one Reddit user mention found
  • Small UK vendor; 1,380 LinkedIn followers, no named public customers

Sources & method

Analyzed 10/06/2026 - 11 sources - No known vulnerabilities found in the sources reviewed.

official x4review x2security x2news x3

Key stats

  • Feature depth: 4/5

    Rating

  • Not disclosed

    Starting price

  • 11

    Sources

  • Analyzed

  • Value for money. No pricing evidence published
  • Ease of use. No usability evidence in sources
  • Feature depth: 4/5. Pricing, suppliers, registrations, shortages, trials, plus developer API
  • Support quality. No support evidence in sources
  • Security posture: 3/5. MFA and RBAC documented; no audit evidence
  • November 2022 Founded Cardiff, UK
  • 20+ Countries served per company About page
  • January 2024 First version ~14 months after founding
  • 1,380 LinkedIn followers company page

Pricing

Not disclosed

Security

No known vulnerabilities found in the sources reviewed.

What users say

Independent user feedback is scarce; one international pharma worker on Reddit uses it for cross-market price and registration comparisons.

“I work in international pharma, and I use tools like PharmaFootpath to compare prices between different markets, and where drugs are being...”
Reddit, r/mounjarouk
Full analysis

Based on 11 public sources; independent user reviews limited to one Reddit thread.

Lean IQVIA alternative for pharma trade teams: global price, supplier, shortage data. No public pricing; demo-gated.

Methodology

Based on 11 public sources; independent user reviews limited to one Reddit thread.

Sources

  1. PharmaFootpath homepagepharmafootpath.com
    official
  2. About PharmaFootpathpharmafootpath.com
    official
  3. PharmaFootpath: Trade-Focused Alternative to IQVIApharmafootpath.com
    official
  4. Privacy Policypharmafootpath.com
    security
  5. Terms and Conditionspharmafootpath.com
    security
  6. Crunchbase company profilecrunchbase.com
    news
  7. Pharmafootpath Ltd company filingsformationdata.co.uk
    news
  8. Reddit thread, r/mounjaroukreddit.com
    review
  9. Pharma Footpath LinkedInuk.linkedin.com
    official
  10. Prospeo: Pharma Footpath descriptionprospeo.io
    news
  11. Should I Use IQVIA reviewshouldiuse.io
    review

Rate this review

Anonymous. You can change your vote.

Loading votes…

Comments

One queue. No nested comments. Give a display name first. Limit: 200 words per comment and 7 comments per day. You can edit or delete yours.

Save a name to write a comment.

0 / 200 words

No comments yet.